Skip to main content
. 2019 Feb 12;31(6):881–887. doi: 10.1007/s40520-019-01138-1

Table 4.

Incremental cost-effectiveness ratio results of studies that used pCGS–sensitivity analyses

At 3 months At 6 months At 36 months
QALY change pCGS 0.00365489 0.01207722 0.19225352
QALY change placebo 0.00031524 0.00310523 0.13181955
Median cost pCGS 139.83 279.66 1677.96
Median ICER 41,869.6 31,170.3 27,765.1
Lowest cost pCGS 115.05 230.1 1380.6
Lowest ICER 34,449.7143 25,646.468 22,844.7678
Higesth cost pCGS 155.76 311.52 1869.12
Highest ICER 46,639.6132 34,721.3721 30,928.301